Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cholangitis Interventions: Drug: Fenofibrate 200mg; Drug: Placebo; Drug: UDCA Sponsor: Xijing Hospital of Digestive Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate
Conditions: Type 2 Diabetes; Cardiovascular Diseases; Pharmacogenomic Drug Interaction Interventions: Drug: Fenofibrate 145 mg; Drug: Placebo Sponsor: Mario Luca Morieri Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials